Ketoprofen;Tulathromycin

Verify with FDA CVM →

213 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
213
Total Reports
128
Deaths Reported
6010.0%
Death Rate

Active Ingredients

Ketoprofen;Tulathromycin

Administration Routes

SubcutaneousUnknownTopicalOtherOphthalmicIntramuscularIntravenousIntraocularIntradermal

Species Affected

Cattle 163
Unknown 27
Human 18
Sheep 5

Most Affected Breeds

Mixed (Cattle) 115
Unknown 46
Aberdeen Angus 15
Cattle (other) 9
Holstein-Friesian also known as Holstein 6
Jersey 5
Crossbred Bovine/Cattle 3
Sheep (unknown) 2
Cattle (unknown) 2
Guernsey 2

Most Reported Reactions

Death 118
Lack of efficacy - NOS 111
Necropsy performed 19
Intentional misuse 13
Containers, Damaged 10
Inappropriate packaging or design 8
Anaphylaxis 8
Injection site swelling 7
Puncture wound 7
Lying down 6
Lack of efficacy (bacteria) - NOS 6
Lateral recumbency 5

Outcome Breakdown

Died
126 (42.9%)
Outcome Unknown
101 (34.4%)
Ongoing
28 (9.5%)
Recovered/Normal
24 (8.2%)
Recovered with Sequela
10 (3.4%)
Euthanized
5 (1.7%)

Data Summary

Metric Value
Total adverse event reports 213
Reports involving death 128
Case-fatality rate (reported events) 6010.0%
Distinct species in reports 4
Distinct breeds in reports 17
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ketoprofen;Tulathromycin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 213 adverse event reports referencing Ketoprofen;Tulathromycin, including 128 reports in which the animal died — a 6010.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ketoprofen;Tulathromycin. Reported administration routes include Subcutaneous, Unknown, Topical, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ketoprofen;Tulathromycin reports are Cattle (163 reports), Unknown (27 reports), Human (18 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (115), Unknown (46), Aberdeen Angus (15) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ketoprofen;Tulathromycin are Death (118), Lack of efficacy - NOS (111), Necropsy performed (19), Intentional misuse (13). Of the 294 reports with a coded outcome, Died is the leading category at 42.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ketoprofen;Tulathromycin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial